Home diagnostic appeal Target healthcare providers and payers emphasizing the PCA 500’s home ECG capability and cloud-connected results to expand remote monitoring programs, reduce in-clinic visits, and improve patient engagement in cardiac care.

Clinical validation Leverage the demonstrated equivalency to Philips ECG and high usability by untrained patients to approach hospitals, clinics, and cardiology practices aiming to improve accuracy, workflow efficiency, and patient throughput for 12-lead ECG testing.

Rapid deployment Position the PCA 500 as a quick-to-scale solution with disposable sensors and a compact form factor to fit in ambulatory care, small clinics, home health, and telemedicine programs seeking portable, low-burden ECG capabilities.

Strategic partnerships Proactively pursue advisers and strategic partners in medical devices, telemedicine platforms, and digital health ecosystems to accelerate integration, data interoperability, and co-development opportunities.

Clinical event momentum Capitalize on recent ACC, NTI, and Octane OC awards/f rebates and ongoing trade show presence to generate lead flow, sponsor demonstrations, and convert interest from attendees into trials and pilot programs.